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Background: Cognitive impairment following a minor stroke or transient ischemic attack
(TIA) is common; however, due to diagnostic difficulties, the prevalence and underlying
cause of impairment remain poorly defined. We compared cognition in patients after a
minor stroke, TIA, or mimic event at three time points in the first year following the event.
We examine whether cognitive impairment occurs following these events and whether
this impairment differs based on the event type. Further, we measure whether these
findings persist after controlling for age, education, and the presence of vascular risk
factors and whether the presence of vascular risk factors, independent of event etiology,
is associated with cognitive impairment. Lastly, we investigate whether increased stroke
risk, as assessed by the ABCD2, is associated with reduced cognition.
Methods: Medical information, a cognitive screening test, and a measure of executive
functioning were collected from 613 patients (123minor stroke, 175 TIA, and 315mimics)
using phone interviews at three time points in the first year following the event. Linear
mixed models were used to determine the effect of event type, vascular risk factors, and
predicted stroke risk on cognitive performance while controlling for confounders.
Results: There was no relationship between event type and performance on either
cognitive measure. When all confounders are controlled for, performance on the cognitive
screening test was uniquely accounted for by the presence of heart failure, myocardial
infarction, angina, and hypertension (all p < 0.047), whereas the measure of executive
functioning was uniquely accounted for by the presence of hypertension and angina (all
p < 0.032). Increased stroke risk also predicted performance on the cognitive screening
test and the measure of executive functioning (all p < 0.002).
Conclusions: Our findings indicate that cognitive impairment following a minor stroke
or TIA may be attributed to the high prevalence of chronic vascular risk factors in these
patients. This highlights the importance of long-termmanagement of vascular risk factors
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beyond event recovery to reduce the risk of cognitive impairment. Increased stroke
risk (i.e., ABCD2 score) was also associated with reduced cognition, suggesting
that it may be helpful in signaling the need for further cognitive evaluation and
intervention post-event.
Keywords: cognition, transient ischemic attack, minor stroke, vascular risk factors, cognitive impairment
INTRODUCTION
Minor stroke and transient ischemic attack (TIA) are brief
episodes of neurological dysfunction that lie on a spectrum
of severity, with minor stroke considered a more severe
neurological event (1). While clinical symptoms are transient,
there is increasing evidence of persistent moderate cognitive
impairment (2, 3). Moreover, patients frequently complain of
persistent memory problems, confusion, and fatigue (4) that
interfere with activities of daily living and reduce quality of
life (5). The rate of moderate (29–68%) and severe (5–22%)
cognitive impairment varies across studies (3). This variability
is likely to be partly due to clinical factors that affect diagnosis,
as symptoms are often resolved before clinical assessment and
diagnosis is often based on clinician’s interpretation of the
patients’ recollection of the event. Moreover, as some non-
vascular conditions (e.g., episodes of migraine, seizure, or
vestibular disturbance) mimic the symptoms of minor stroke
and TIA (6), it is possible that some studies that do not include
specialist diagnosis may inadvertently include a proportion of
mimic patients for whom changes in cognitive functioning have
not been specifically established.
Estimates of cognitive impairment in minor stroke and
TIA patients may also be inflated by the failure to control
for the pre-event presence of vascular (e.g., hypertension and
hyperlipidemia) and non-vascular (e.g., age and education level)
risk factors that are known to impact cognitive functioning (7).
Vascular risk factors accelerate the progression of atherosclerosis,
resulting in decreased blood flow and higher risk of white
matter damage (8) and vascular events (9). White matter damage
associated with vascular risk factors is most prominent in the
prefrontal cortex, an area that supports executive functions (2,
10). Age-related changes in brain structure and cognition are
accelerated 2-fold over a 5-year period in people with vascular
risk factors compared to age-matched controls (11, 12). Minor
stroke and TIA patients have a greater prevalence of vascular
risk factors than do healthy controls (2, 13) and a greater rate
of neural atrophy over a 3-year period (14). Therefore, cognitive
complaints associated with these minor neurological events may,
in fact, arise from more chronic vascular disease processes
predating or following on from the focal ischemic damage caused
by the event itself.
In this study, we investigate cognitive functioning during the
first year after a minor stroke, a TIA, or a mimic event. We
examine whether cognitive functioning varies as a function of
event type and, if so, whether these differences can be attributed
to the differential presence of vascular risk factors. As a minor
stroke is a more severe vascular event than a TIA, we expect that
it will be associated with poorer cognitive performance. Likewise,
we expect that TIA will be associated with poorer cognition than
the range of transient mild symptoms that characterize mimic
events. We expect that vascular risk factors will also be associated
with poorer cognitive ability, independently of event etiology.
However, if the neurological impact of minor stroke and TIA is
greater than the impact of vascular risk factors, event type effects
on cognition are expected to persist when controlling for vascular
risk factors. Finally, we examine the clinically important question
of whether risk of future stroke, assessed using the ABCD2,
can predict cognition, independently of event type and vascular
risk factors.
METHODS
The International Systems of Care and Patient Outcomes in
Minor Stroke and TIA (INSIST) is a longitudinal, community-
based inception cohort study that was approved by the Hunter
New England Health and the University of Newcastle Human
Research Ethics Committees (12/04/18/4.02; H-2012-0154). All
patients provided written informed consent.
Six hundred and thirteen patients who presented to
16 primary and secondary care practices, including general
practices, emergency departments, acute neurovascular clinics,
stroke units, and hospitals in the Hunter and Manning Valley
regions of New South Wales, Australia, with a possible stroke or
TIA diagnosis were recruited into the study (15).
Adjudication of the presenting event as a minor stroke,
TIA, or mimic event was completed by a specialist clinical
panel including two stroke neurologists, a general practitioner,
and an academic neuroradiologist using a standardized clinical
definition across all practices (see Table 1). Adjudication was
based on a consensus decision across the panel using the
patient’s narrative of the baseline event, clinical symptom
TABLE 1 | Criteria for adjudication of a TIA, minor stroke, or mimic event in the
INSIST study.
Adjudicated group INSIST criteria
Transient ischemic attack Rapidly developing clinical signs of focal
disturbance of cerebral function lasting less than
24 h with no apparent non-vascular cause
Minor stroke A stroke with a National Institutes of Health Stroke
Scale score of less than or equal to 4 lasting more
than 24 h
Mimic event Neurological disturbance with no apparent vascular
cause
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duration, and type (i.e., positive or negative), modality (e.g.,
motor or sensory), and medical information (i.e., neuroimaging,
clinical, and radiological information). As the study recruited
from primary care facilities without access to medical imaging
facilities, clinical MRI was unavailable for many patients.
At baseline, 123 events were adjudicated as a minor stroke,
175 as a TIA, and 315 as a mimic (see Supplementary Table 1
for information on neurovascular event subtype, territory, and
mimic diagnosis). Recurrent events that occurred after the
baseline event were clinically adjudicated at each interview using
the same adjudication panel, criteria, and medical information
as baseline events. However, as the focus of this study was to
examine the effect of a baseline event on cognition, only the
patient’s baseline event diagnosis was used to determine event
type for this study.
Procedure
Following their index event, participants completed three phone
interviews which included demographic, neurological, cognitive,
and affective measures. Due to logistical factors in recruitment
and interview scheduling, the time from the baseline event to
each interview varied across participants. As a result, we used
time since event rather than interview occasion to assess change
in outcomes post-event. Specifically, time was converted into
a categorical variable based on days since the baseline event,
producing three time points. Time Point 1 included interviews
conducted 80 days post-event, Time Point 2 included interviews
conducted 81–335 days post-event, and Time Point 3 included
interviews conducted more than 335 days post-event (maximum
1,000 days; see Table 2). The majority of first, second, and third
interviews were included in time points 1, 2, and 3, respectively.
Dependent Variables: Cognitive Functioning
The Telephone Interview for Cognitive Status [TICS; (16)]
is an 11-item cognitive screening test (maximum score 41).
The TICS has been validated against the Mini-Mental State
Examination (17).
The semantic Verbal Fluency Task [VFT; animal names in
1min, (18)] was used as a measure of executive functions. It has
been validated for use over the telephone (19) with scores over 13
indicating healthy performance in older adults (20).
Independent Variables: ABCD2 Score, Vascular Risk
Factors, Patient Demographics, Mood
The ABCD2 score is a risk stratification tool designed to identify
the predicted risk of stroke in patients who present to acute
care with a minor stroke or a TIA. The ABCD2 is used as a
guide to emergency assessment and treatment, predicting the
risk of stroke at 2, 7, and 90 days post-event (21). The ABCD2
combines significant clinical features of a minor neurological
event and vascular risk factors to categorize a patient’s risk of
future stroke. As is common in the literature (22, 23), ABCD2
scores were analyzed as a categorical variable with three groups,
each indicating a different risk of future stroke: low (scores of
0–3), moderate (scores of 4–5), and high (scores of 6–7).
Patient demographics included age at the time of event, sex,
years of education, and the presence of vascular risk factors
(hypertension, hyperlipidemia, myocardial infarction, heart
failure, angina, peripheral vascular disease, atrial fibrillation, and
diabetes). The presence of vascular risk factors at baseline was
based on clinical diagnosis by the attending clinician.
The Hospital Anxiety and Depression Scale [HADS, (24)] is
a self-assessment scale for depression and anxiety in a medical
environment with good psychometric properties in psychiatric,
primary care patients and the general population (25). A score
of >11 (range 0–21) on the HADS indicates a higher risk of
depression (24).
The modified Rankin Scale [mRS, (26)] measures the degree
to which physical disability following a stroke impedes daily
activities. Scores range from 0 to 6, with higher scores indicating
greater levels of disability. mRS scores were obtained at each time
point, and a pre-event mRS score was derived retrospectively
using information from patients and carers. Pre- and post-event
mRS scores show good concurrent validity and are a robust
predictor of prognosis (27, 28).
Statistics
Event type effects (minor stroke, TIA, andmimic) were examined
using a one-way ANOVA for continuous variables (age), a
Kruskal–Wallis H test for discrete variables (number of vascular
risk factors, categorized ABCD2 score, and mRS), and a chi-
square test of independence for categorical variables [attrition,
vascular risk factor presence, sex, depression (>11 on theHADS),
and low education (≤12 years of formal education), (29)] and
TABLE 2 | Summary of recategorization from interview occasion (columns) to time points (rows) used to analyze time since event in lieu of interview occasions.
Interview occasion
1 2 3
Days post-event (mean ± SD) 57 ± 50 150 ± 53 381 ± 41
Time point Days post-event n n n Total N
1 0–80 497 0 1 498
2 81–335 113 603 7 723
3 336+ 3 5 603 611
Total N 613 608 611 1,832
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summarized using the mean and standard deviation. Significant
main effects of event type were examined using simple contrasts
between group pairs. Post-hoc power analysis found that the
INSIST sample size had 80% power to detect a moderate effect
size of 0.35 (Cohen’s D) for these continuous outcomes when
comparing any two groups.
Linear mixed models were built in Stata (version 14) to
examine crude main effects of each independent variable (IV;
event type, grouped ABCD2 score, and vascular risk factors) on
each dependent variable (DV; TICS and VFT) across time points.
The crude model for each IV also included a term for time point
as a categorical variable and a random effect to control for the
correlation of repeatedmeasures on individuals. Adjustedmodels
were created to examine whether any significant main effect of
the IV survived after adjusting for potential confounders for each
IV–DV relationship.
Directed acyclic graphs (DAGs) for each model were derived
to theoretically characterize the relationship between each IV and
DV and to identify confounders that needed to be controlled in
order to estimate the total effect of the IV on the DV (30). Based
on the DAG, to identify the independent effect of event type on
cognition (Model 1), we needed to control for age and all vascular
risk factors. For each vascular risk model (Model 2), we needed
to control for education, depression, age, and all other vascular
risk factors. For these models, the DAG identified that event type
was a potential mediator. To examine whether event type affected
the relationship between vascular risk factors and cognition, in
initial analyses, event type was included in each vascular risk
model. As its inclusion scarcely changed findings, event type was
not included in the vascular risk models presented below. For
the ABCD2 model (Model 3), we controlled for event type and
all vascular risk factors excluding hypertension and diabetes, as
they contribute to the ABCD2 score. For all models, there was
no evidence of violation of the model assumptions of linearity,
non-constant variance, and normality of the residuals.
RESULTS
Of the 613 participants, two were missing both TICS and VFT
scores and were removed from further analyses (N = 611). We
used mixed model analysis for these longitudinal data, so data
from all 611 participants contributed to the analyses, even if there
were missing data on one or two time points.Table 3 summarizes
the number of participants who completed the TICS and VFT at
each interview occasion.
Twenty participants completed the TICS and VFT only on
their first interview occasion and were thereafter lost to follow-
up. These 20 participants were older (p < 0.001) and performed
more poorly on both the TICS and VFT measures at Time Point
1 (p= 0.001 and p= 0.036, respectively; data not tabulated) than
participants who contributed to additional data points. Excluding
these participants from all analyses below did not change the
pattern of findings, so they were retained.
As shown in Table 4, the three event types differed
significantly on a number of demographic and risk variables.
There were significant group differences in sex (p < 0.001),
TABLE 3 | Summary of the number of participants who provided cognitive
measures at each interview.
Number of interview(s) completed TICS VFT
Interview 1 Only 20 (3.3%) 20 (3.3%)
Interview 2 Only 1 (0.2%) 3 (0.5%)
Interview 3 Only 0 1 (0.2%)
Interviews 1 and 2 25 (4.1%) 27 (4.4%)
Interviews 1 and 3 12 (2.0%) 15 (2.5%)
Interviews 2 and 3 1 (0.2%) 14 (2.3%)
All interviews 552 (90.3%) 531 (86.9%)
Total data obtained 611 611
ABCD2 categories (p < 0.001), number of vascular risk factors
(p < 0.001), and prevalence of all vascular risk factors excluding
hyperlipidemia and diabetes (all p < 0.033). Comparisons (data
not tabulated) revealed that minor stroke and TIA patients had
a higher percentage of males compared with mimic patients (p
< 0.001). Minor stroke patients had significantly higher ABCD2
scores and number of vascular risk factors compared to both
TIA and mimic patients, and TIA patients had higher ABCD2
scores and number of vascular risk factors compared to mimic
patients (all p< 0.001). Group differences regarding the presence
of vascular risk factors were driven by a greater prevalence in
minor stroke and TIA patient groups (see Table 4).
Cognitive and Disability Changes Across
Time Points
As shown in Table 5, TICS scores increased progressively over
post-event time points [N = 611, χ2(2)= 74.17, p< 0.001; Time
Points 1 to 2: 95%CI,−1.11 to−0.28; Time Points 2 to 3: 95%CI,
0.02 to 0.83]. Although statistically significant, the total increase
of 1.1 score (maximum = 41) is not clinically significant. VFT
scores did not vary across time points [N = 611, χ2(2) = 0.65,
p = 0.724]. mRS scores varied significantly over time [N = 611,
χ
2(3) = 92.67, p < 0.001]. There was a substantial increase in
disability from pre-event to Time Point 1 (95% CI, 0.11 to 0.21)
and a smaller but progressive increase thereafter (Time Points 1
to 2: 95% CI, 0.12 to 0.22; Time Points 2 to 3: 95% CI, 0.18 to
0.28). Depression scores varied significantly over time [N = 611,
χ
2(2) = 32.71, p < 0.001], decreasing slightly from Time Points
1 to 2 (95% CI,−0.49 to 0.17) and significantly from Time Points
2 to 3 (95% CI,−0.94 to−0.25).
Time point was included in all three models below but did not
interact with either TICS or VFT in any of the three models and
will not be discussed further (all p> 0.150; data not tabulated).
Model 1: Event Type on Cognition
In the crude main effects model for event type (Table 6), TICS
scores did not vary with event type. There was a small but
significant effect of event type on VFT, with simple comparisons
indicating that minor stroke patients performed more poorly
than mimic patients (p = 0.008; data not tabulated). Including
age as a potential confounder (adjusted model) reduced all
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TABLE 4 | All participants’ sociodemographic, vascular, and lifestyle risk factors by event type.
Minor stroke TIA Mimic Total F/χ2 df p Direction of significant effect
N = 123 (20%) N = 175 (29%) N = 315 (51%) N = 611
Age (Mean ± SD) 73 ± 10 72 ± 11 68 ± 13 70 ± 12 1.20 2, 611 0.153 Mi < TIA***
Mi < MS***
Sex (% Male) 67 (54%) 104 (59%) 107 (34%) 278 (45%) 34.6 2 <0.001 Mi < TIA***
Mi < MS***
Grouped ABCD2 (% Yes)
Low risk (0–3) 17 (14%) 92 (53%) 202 (64%) 311 (51%) 91.0 2 <0.001 Mi < TIA***
Moderate risk (4–5) 65 (53%) 59 (34%) 95 (30%) 219 (36%) Mi < MS***
High risk (6–7) 41 (33%) 23 (13%) 14 (4%) 78 (25%) TIA < MS***
Vascular risk factor (% Yes)
Hypertension 100 (81%) 123 (70%) 202 (64%) 425 (70%) 12.4 2 0.002 Mi < MS***
Hyperlipidemia 70 (57%) 96 (55%) 155 (49%) 321 (52%) 2.7 2 0.257 Mi < MS***
Myocardial infarction 27 (22%) 22 (13%) 24 (8%) 73 (12%) 17.4 2 <0.001 TIA < MS*
Heart failure 16 (13%) 17 (10%) 18 (6%) 51 (8%) 6.8 2 0.033 Mi < MS*
Angina 30 (25%) 31 (18%) 40 (13%) 101 (17%) 9.1 2 0.011 Mi < MS*
Peripheral vascular disease 11 (9%) 18 (10%) 11 (3%) 40 (7%) 10.0 2 0.007 Mi < TIA**
Atrial fibrillation 26 (21%) 41 (23%) 35 (11%) 102 (17%) 14.6 2 0.001 Mi < TIA**
Diabetes 29 (24%) 30 (17%) 47 (15%) 106 (17%) 4.6 2 0.098 Mi < MS*
No. vascular risk factors (mean ± SD) 2.51 ± 1.64 2.16 ± 1.52 1.69 ± 1.35 1.99 ± 1.49 27.5 2 <0.001 Mi < TIA***
Mi < MS***
TIA < MS***
Lifestyle risk factor (% Yes)
Low education 59 (48%) 86 (49%) 135 (43%) 280 (46%) 2.1 2 0.347
Depression 13 (11%) 17 (10%) 27 (9%) 57 (9%) 1.4 2 0.492
*p < 0.05, **p < 0.010, ***p < 0.001, Mi, mimic; MS, minor stroke. Shaded p-values indicate p < 0.05.
TABLE 5 | Mean cognitive and disability measures over time points.
Minor stroke TIA Mimic χ2 df p
Telephone interview for cognitive status (Mean ± SD)
Time 1 32.85 ± 3.83 33.47 ± 3.83 33.82 ± 3.53 74.2 2 <0.001
Time 2 33.76 ± 3.65 34.53 ± 3.48 34.21 ± 3.45
Time 3 34.59 ± 4.01 34.53 ± 3.56 34.72 ± 3.74
Mean over time 33.73 ± 3.83 34.18 ± 3.62 34.25 ± 3.57
Verbal fluency test (Mean ± SD)
Time 1 17.65 ± 5.65 18.78 ± 5.62 20.23 ± 6.15 0.6 2 0.724
Time 2 18.86 ± 6.45 19.27 ± 6.45 19.60 ± 6.28
Time 3 18.75 ± 6.39 18.72 ± 6.42 19.88 ± 6.40
Mean over time 18.42 ± 6.16 18.92 ± 6.16 19.90 ± 6.28
Modified rankin scale (Mean ± SD)
Pre-event 0.72 ± 1.13 0.75 ± 1.08 0.68 ± 1.02 92.7 2 <0.001
Time 1 1.25 ± 1.11 0.76 ± 1.05 0.76 ± 1.04
Time 2 1.27 ± 1.16 0.82 ± 1.12 0.76 ± 1.03
Time 3 1.37 ± 1.15 0.93 ± 1.16 0.78 ± 1.07
Mean over time 1.15 ± 1.14 0.82 ± 1.10 0.75 ± 1.04
Hospital anxiety and depression scale (Depression component) (Mean ± SD)
Time 1 3.31 ± 0.19 2.91 ± 0.17 2.94 ± 0.15 32.7 2 <0.001
Time 2 3.16 ± 0.18 2.75 ± 0.15 2.78 ± 0.13
Time 3 2.72 ± 0.18 2.31 ± 0.17 2.34 ± 0.14
Mean over time 3.06 ± 0.18 2.66 ± 0.16 2.69 ± 0.14
Shaded p-values indicate p < 0.05.
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TABLE 6 | Effects of event type on TICS and VFT.
Cognitive measures by event type
Crude Adjusted Final
Outcome β 95% CI p β 95% CI p β 95% CI p
Telephone interview for cognitive status
MS–TIA −0.60 −1.4 to 0.2 0.213 −0.56 −1.3 to 0.2 0.252 −0.32 −1.2 to 0.1 0.191
Mimic–TIA 0.00 −0.6 to 0.6 −0.41 −1.0 to 0.2 −0.53 −2.3 to 0.7
MS–Mimic −0.60 −1.2 to 0.1 −0.15 −0.8 to 0.5 0.21 -0.4 to 0.8
Verbal fluency test
MS–TIA −0.69 −2.0 to 0.6 0.022 −0.60 −1.8 to 0.6 0.441 −0.24 −1.4 to 0.9 0.910
Mimic–TIA 0.87 -0.1 to 1.9 0.10 −0.9 to 1.1 −0.04 −1.0 to 0.9
MS–Mimic −1.60 −2.7 to −0.4 −0.70 −1.8 to 0.4 −0.20 −1.3 to 0.9
Left: Crude models including event type and time point. Middle: Adjusted model including time and controlling for age. Right: Final model including time and controlling for age and
vascular risk factors. Shaded beta values indicate significant confidence intervals and significant findings (α < 0.05).
coefficients and removed the relationship between VFT scores
and event type. The final TICS and VFT models that controlled
for both age and vascular risk factors resulted in further reduced
coefficients. The addition of depression in the model scarcely
affected coefficients from those presented and was not included
in any of the event type models.
Model 2: Vascular Risk Factors on
Cognition
Table 7 shows that both TICS and VFT scores were significantly
lower in the presence of most individual vascular risk factors. For
TICS scores, the strongest predictor was heart failure, followed
in decreasing order by myocardial infarction, angina, peripheral
vascular disease, hypertension, and atrial fibrillation. For VFT,
the strongest predictor was again heart failure, followed by
hypertension, angina, myocardial infarction, peripheral vascular
disease, atrial fibrillation, and hyperlipidemia. Controlling for age
and education reduced the strength of the effect of each vascular
risk factor on both TICS and VFT. The final models for each
vascular risk factor also controlled for all other vascular risk
factors. As shown in Table 7, when controlling for other vascular
risk factors, the only vascular risk factors to uniquely significantly
predict TICS were, in descending order, heart failure, myocardial
infarction, angina, and hypertension. For VFT scores, only
hypertension and angina remained as unique predictors. The
addition of depression and event type scarcely altered coefficients
from those presented above and therefore were not included in
any of the vascular risk factor models.
Model 3: ABCD2 on Cognition
Table 8 shows that greater risk of stroke was associated with
significantly lower TICS and VFT scores. All relationships
remained significant when controlling solely for event type
(adjusted model) and together with vascular risk factors (final
model). Simple comparisons (data not tabulated) revealed
significant differences on TICS scores between all groups (low
risk vs. moderate risk p = 0.008, low vs. high p < 0.001, and
moderate vs. high p = 0.036) and on VFT scores between
low- and moderate-risk groups (p = 0.002) and low- and high-
risk groups (p = 0.009). Performance on the VFT did not
differ between moderate- and high-risk groups (p = 0.572). The
addition of depression in the model scarcely affected coefficients
from those presented and was not included in any of the ABCD2
models.
DISCUSSION
The present study used a cognitive screening test (TICS) and
a brief measure of executive functioning (VFT) to investigate
differences in the level and progression of cognitive ability in
the first year after a minor stroke, TIA, or mimic event. We
sought to identify whether cognitive ability was differentially
impacted by event severity, independently of the presence of
coexisting, chronic vascular disease processes associated with
vascular risk factors.
Across the first year following a minor neurological event,
there was a small but statistically significant improvement in
performance on the cognitive screening test but not the measure
of executive functioning. The increase in TICS score was not
clinically significant; did not differ by event type, presence of
vascular risk factor, or risk of future stroke; and remained when
removing the few participants (3%) who only completed the first
interview. This small increase in TICS may reflect slight recovery
of cognition following a brief disruption after an event and/or test
practice effect.
Event Type
Event type had a significant effect on the measure of executive
functioning that was driven by poorer performance in the minor
stroke group compared to the mimic group. This effect was
weak and was removed after controlling for either vascular
risk factors or age. In conclusion, in this large sample and
using broad cognitive screening tasks, differences in cognitive
functioning between minor stroke, TIA, and mimic events in the
first year post-event were weak and attributable to differential
prevalence of vascular risk factors and/or age. Alternatively, it
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TABLE 7 | Effects of vascular risk factors on TICS and VFT.
Cognitive measures by vascular risk factors
Crude Adjusted Final
Outcome β 95% CI p β 95% CI p β 95% CI p
Telephone interview for cognitive status
Hypertension −1.43 −2.0 to −0.9 <0.001 −0.74 −1.3 to −0.2 0.009 −0.68 −1.3 to −0.1 0.020
Hyperlipidemia −0.36 −0.9 to 0.2 0.183 −0.12 −0.6 to 0.4 0.633 0.28 −0.2 to 0.8 0.296
Myocardial infarction −1.93 −2.7 to −1.1 <0.001 −1.36 −2.1 to −0.6 <0.001 −0.88 −1.7 to −0.1 0.004
Heart failure −2.48 −3.4 to −1.5 <0.001 −1.5 −2.4 to −0.6 0.001 −0.96 −1.9 to 0.0 0.047
Angina −1.84 −2.5 to −1.1 <0.001 −1.21 −1.9 to −0.5 <0.001 −0.77 −1.5 to 0.0 0.038
Peripheral vascular disease −1.77 −2.8 to −0.7 0.001 −0.8 −1.8 to 0.2 0.119 0.01 −1.0 to 1.1 0.983
Atrial fibrillation −1.13 −1.8 to −0.4 0.002 −0.3 −1.0 to 0.4 0.394 −0.08 −0.8 to 0.6 0.804
Diabetes −0.42 −1–1 to 0.3 0.245 −0.33 −1.0 to 0.3 0.307 −0.08 −0.7 to 0.6 0.804
Verbal fluency test
Hypertension −3.01 −3.9 to −2.1 <0.001 −1.69 −2.6 to −0.8 <0.001 −1.39 −2.3 to −0.5 0.004
Hyperlipidemia −1.52 −2.4 to −0.6 <0.001 −0.98 −1.8 to −0.2 0.017 −0.39 −1.2 to 0.5 0.368
Myocardial infarction −2.5 −3.9 to −1.1 <0.001 −1.43 −2.7 to −0.2 0.024 −0.53 −1.9 to 0.8 0.436
Heart failure −3.98 −5.6 to −2.4 <0.001 −2.25 −3.7 to −0.8 0.003 −1.46 −3.0 to 0.1 0.067
Angina −2.90 −4.1 to −1.7 <0.001 −1.77 −2.9 to −0.7 0.001 −1.31 −2.5 to −0.1 0.032
Peripheral vascular disease −2.21 −4.0 to −0.4 0.016 −0.55 −2.2 to 1.1 0.516 0.74 −1.1 to 2.5 0.404
Atrial fibrillation −2.04 −3.2 to −0.9 <0.001 −0.53 −1.6 to 0.6 0.348 −0.34 −1.4 to 0.8 0.555
Diabetes −0.86 −2.0 to 0.3 0.146 −0.33 −1.7 to 0.4 0.219 −0.14 −1.2 to 0.9 0.798
Left: Crude models for each vascular risk factor including only time. Middle: Adjusted model including time and controlling for age and education. Right: Final model including time and
controlling for age, education, and all other vascular risk factors. Shaded beta values indicate significant confidence intervals and significant findings (α < 0.05).
TABLE 8 | Effects of ABCD2 on cognition.
Cognitive Measures by ABCD2
Crude Adjusted Final
Outcome β 95% CI p β 95% CI p β 95% CI p
Telephone interview for cognitive status
Mod–Low −0.82 −1.4 to −0.3 <0.001 −0.85 −1.5 to −0.2 <0.001 −0.79 −1.37 to −0.2 <0.001
High–Low −1.77 −2.5 to −0.9 −1.82 −2.7 to −0.9 −1.7 −2.57 to −0.8
High–Mod −0.94 −1.8 to −0.8 −0.97 −1.9 to −0.1 −0.91 −1.8 to −0.1
Verbal fluency test
Mod–Low −1.78 −2.7 to −0.8 <0.001 −1.6 −2.7 to −0.7 <0.001 −1.53 −2.5 to -0.6 0.002
High–Low −2.58 −3.9 to −1.2 −2.3 −3.8 to −0.8 −1.94 −3.4 to −0.5
High–Mod −0.80 −2.2 to 0.6 −0.66 −2.1 to 0.8 −0.41 −1.8 to 1.0
Left: Crude models including ABCD2 and time point. Middle: Adjusted model including time and controlling for event type. Right: Final model including time and controlling for
hyperlipidemia, myocardial infarction, heart failure, angina, peripheral vascular disease, atrial fibrillation, and event type. Shaded beta values indicate significant confidence intervals
and significant findings (α < 0.05).
is possible that the broad cognitive measures used in this study
were not sufficiently sensitive to detect subtle differences as a
function of event type. It is possible that more sensitive cognitive
tasks and functional brain imaging measures may reveal more
subtle impairments.
Other studies suggest that both neural structure and cognitive
function are affected in the subacute stage following a minor
stroke or TIA. Bivard et al. (31) found that, compared to
healthy controls with a similar number of vascular risk factors,
both minor stroke and TIA patients who had evidence of
acute ischemia in brain perfusion imaging showed cerebral gray
matter atrophy from baseline to 90 days post-event as well
as poorer performance on executive function and attention
subscales of the Montreal Cognitive Assessment (MoCA). There
is less consistent evidence for long-term cognitive impairment
following a TIA or minor stroke. Munir et al. (14) reported
that, although minor stroke and TIA patients had a higher
rate of neural atrophy and slower processing speed compared
to healthy controls over a 3-year period, neither memory nor
executive functions were affected. Similarly, Sachdev et al. (32)
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found that, at 3 years post-event, minor stroke and TIA patients
showed reduced verbal memory but no difference in any other
cognitive domain, when compared to controls. Taken together,
these findings suggest that although minor stroke and TIA may
be associated with cognitive decline in the early post-event
periods [e.g., 90 days in Bivard et al. (31)], the effects on cognition
are only transient.
Vascular Risk Factors
Consistent with many previous studies (33–37), the presence of
vascular risk factors was associated with reduced performance on
both the cognitive screening task and the executive functioning
measure. When we examined the unique contribution of each
vascular risk factor and controlled for age and education,
performance on the cognitive screening test was significantly
impaired, in decreasing order of impact, by the presence of
heart failure, myocardial infarction, angina, and hypertension,
whereas executive function scores were significantly impacted by
hypertension and angina.
Minor stroke patients had a greater prevalence of each of
these vascular risk factors that independently affected cognitive
performance; however, inclusion of event type as a confounder
did not impact the relationship between vascular risk factors
and cognition. While it is well established that vascular risk
factors affect cognition, this finding provides evidence that the
reported cognitive dysfunction after a minor stroke or TIA
may be attributed to the increased prevalence of vascular risk
factors in such patients. Moreover, the robust findings between
vascular risk factors and cognitive ability after controlling for
a number of confounders suggest that these broad cognitive
measures are sufficiently sensitive to progressive effects arising
from vascular factors. This suggests that the null finding of event
type (discussed above) is unlikely to be due to test insensitivity.
Predicted Stroke Risk
As expected, ABCD2 scores were highest in minor stroke
patients, followed by TIA and mimic patients. This finding
supports the use of the ABCD2 score as a tool to assist in
diagnostic decisions, especially in clinical settings that may not
have access to imaging or specialist resources. Further, we found
that increased predicted risk of future stroke was associated
with reduced performance on both cognitive tests, even after
controlling for event type and vascular risk factors (excluding
hypertension and diabetes which contribute to the ABCD2
score). As there was no evidence of a relationship between
cognition and either event type or diabetes, it is likely that the
relationship between cognition and stroke risk is driven by the
other variables that contribute to the ABCD2 score, such as age
and hypertension.
CONCLUSION
A large community-dwelling cohort of patients with a clinical
diagnosis of minor stroke, TIA, or mimic event was assessed
over the first year post-event. Level of physical disability and
risk of future stroke progressively increased with event severity.
However, event type was not associated with differential level
of functioning on a cognitive screening test and produced
only a small effect on a measure of executive functioning
that was eliminated after controlling for vascular risk factors
and age. In contrast, the presence of vascular risk factors and
most consistently hypertension and angina, as well as predicted
stroke risk, were associated with reduced performance on both
the cognitive screening and the executive function measures,
irrespective of event etiology and other confounders.
The absence of an effect of neurological event type on
cognition, in the presence of significant effects of future stroke
risk and vascular risk factors, suggests that vascular risk factors
may account, at least partially, for reported levels of cognitive
decline after a minor stroke or TIA. This work supports the
notion that these mild neurological events have only transient
effects on cognitive functioning, suggesting that the common
cognitive complaints reported following such transient events
may arise from the increased prevalence of chronic vascular risk
factors that are present in these patients before the neurological
event. This highlights the need to monitor cognitive functioning
associated with vascular risk factors and, in the absence of
pre-event measures, obtain estimates of pre-event cognition at
the time of the presenting event (38). Finally, the ABCD2,
which also loads heavily on vascular risk factors, varied across
neurological event type andwas associated with cognitive decline,
independently of event type. This is consistent with the role
of vascular risk factors in cognitive decline. Together, these
findings suggest that the presence of vascular risk factors
could signal the need to monitor patients’ cognitive functioning
trajectory and consider appropriate interventions which may aid
in reducing the risk of cognitive decline by improving cognitive
ability. There is emerging evidence suggesting that cognitive
ability can be improved by treating vascular risk factors; for
example, a review by Elias et al. (39) reports multiple studies
displaying an improvement in cognitive ability after treatment
with candesartan in hypertensive patients. Moreover, a review by
Hajduk et al. [(40), see also (41)] reports that patients with heart
failure undergoing interventions to increase cardiac function
displayed cognitive improvements.
A particular strength of this study is the inclusion of a large
community-dwelling cohort that consisted of patients managed
entirely across a range of primary care settings as well as
patients in secondary care. Event adjudication was completed by
a specialist panel using general practitioner, hospital, emergency
department, and specialist notes to accurately diagnose vascular
risk factors. Cognitive ability was assessed using trajectory
analysis at three time points after the event. Based on
these findings, we conclude that clinically adjudicated mild
neurological events do not significantly impact cognition in the
first year post-event, whereas the presence of vascular risk factors
and future stroke risk are associated with lower cognition but not
differential decline over a 1-year period.
This conclusion needs to be considered in light of potential
caveats that may affect its generalization. Firstly, we compared
minor stroke and TIA groups against a mimic group instead
of a healthy control group. While mimic patients constitute
a good clinical control group, these patients had a broad
range of clinical presentations and are likely to perform more
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poorly than a healthy control group. Secondly, in the absence
of clinical imaging, it was not possible to use imaging-based
categorization of minor stroke and TIA or to examine whether
the location of an ischemic event differentially affected cognitive
profile. Thirdly, we did not control for differential effects
of clinical treatment or pre-/post-event medication history.
Fourthly, we did not complete a comprehensive and in-depth
neuropsychological assessment, and therefore, subtle cognitive
differences may have been missed. Finally, in the absence of a
pre-event measure of cognitive ability, it was not possible to
differentiate between premorbid cognitive level and event-related
cognitive effects.
Overall, these findings are consistent with other studies
showing little evidence of persistent cognitive decline post-TIA
or minor stroke (14, 32). Future work is needed to examine
whether behavioral and neuroimaging measures of executive
function processes and associated brain networks are more
sensitive to emerging and potentially reversible levels of cognitive
decline associated with these minor neurological events.
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